261 related articles for article (PubMed ID: 12907596)
1. PML is required for homeodomain-interacting protein kinase 2 (HIPK2)-mediated p53 phosphorylation and cell cycle arrest but is dispensable for the formation of HIPK domains.
Möller A; Sirma H; Hofmann TG; Rueffer S; Klimczak E; Dröge W; Will H; Schmitz ML
Cancer Res; 2003 Aug; 63(15):4310-4. PubMed ID: 12907596
[TBL] [Abstract][Full Text] [Related]
2. Role of the SUMO-interacting motif in HIPK2 targeting to the PML nuclear bodies and regulation of p53.
Sung KS; Lee YA; Kim ET; Lee SR; Ahn JH; Choi CY
Exp Cell Res; 2011 Apr; 317(7):1060-70. PubMed ID: 21192925
[TBL] [Abstract][Full Text] [Related]
3. Homeodomain-interacting protein kinase-2 phosphorylates p53 at Ser 46 and mediates apoptosis.
D'Orazi G; Cecchinelli B; Bruno T; Manni I; Higashimoto Y; Saito S; Gostissa M; Coen S; Marchetti A; Del Sal G; Piaggio G; Fanciulli M; Appella E; Soddu S
Nat Cell Biol; 2002 Jan; 4(1):11-9. PubMed ID: 11780126
[TBL] [Abstract][Full Text] [Related]
4. Regulation of p53 activity by its interaction with homeodomain-interacting protein kinase-2.
Hofmann TG; Möller A; Sirma H; Zentgraf H; Taya Y; Dröge W; Will H; Schmitz ML
Nat Cell Biol; 2002 Jan; 4(1):1-10. PubMed ID: 11740489
[TBL] [Abstract][Full Text] [Related]
5. PML tumor suppressor is regulated by HIPK2-mediated phosphorylation in response to DNA damage.
Gresko E; Ritterhoff S; Sevilla-Perez J; Roscic A; Fröbius K; Kotevic I; Vichalkovski A; Hess D; Hemmings BA; Schmitz ML
Oncogene; 2009 Feb; 28(5):698-708. PubMed ID: 19015637
[TBL] [Abstract][Full Text] [Related]
6. The homeodomain-interacting kinase PKM (HIPK-2) modifies ND10 through both its kinase domain and a SUMO-1 interaction motif and alters the posttranslational modification of PML.
Engelhardt OG; Boutell C; Orr A; Ullrich E; Haller O; Everett RD
Exp Cell Res; 2003 Feb; 283(1):36-50. PubMed ID: 12565818
[TBL] [Abstract][Full Text] [Related]
7. PML-RARα and its phosphorylation regulate pml oligomerization and HIPK2 stability.
Shima Y; Honma Y; Kitabayashi I
Cancer Res; 2013 Jul; 73(14):4278-88. PubMed ID: 23722549
[TBL] [Abstract][Full Text] [Related]
8. Sp100 is important for the stimulatory effect of homeodomain-interacting protein kinase-2 on p53-dependent gene expression.
Möller A; Sirma H; Hofmann TG; Staege H; Gresko E; Lüdi KS; Klimczak E; Dröge W; Will H; Schmitz ML
Oncogene; 2003 Nov; 22(54):8731-7. PubMed ID: 14647468
[TBL] [Abstract][Full Text] [Related]
9. TP53INP1s and homeodomain-interacting protein kinase-2 (HIPK2) are partners in regulating p53 activity.
Tomasini R; Samir AA; Carrier A; Isnardon D; Cecchinelli B; Soddu S; Malissen B; Dagorn JC; Iovanna JL; Dusetti NJ
J Biol Chem; 2003 Sep; 278(39):37722-9. PubMed ID: 12851404
[TBL] [Abstract][Full Text] [Related]
10. Hepatitis C virus core protein inhibits tumor suppressor protein promyelocytic leukemia function in human hepatoma cells.
Herzer K; Weyer S; Krammer PH; Galle PR; Hofmann TG
Cancer Res; 2005 Dec; 65(23):10830-7. PubMed ID: 16322229
[TBL] [Abstract][Full Text] [Related]
11. The Tyrosine Kinase c-Abl Promotes Homeodomain-interacting Protein Kinase 2 (HIPK2) Accumulation and Activation in Response to DNA Damage.
Reuven N; Adler J; Porat Z; Polonio-Vallon T; Hofmann TG; Shaul Y
J Biol Chem; 2015 Jul; 290(27):16478-88. PubMed ID: 25944899
[TBL] [Abstract][Full Text] [Related]
12. Human-herpesvirus-8-encoded K8 protein colocalizes with the promyelocytic leukemia protein (PML) bodies and recruits p53 to the PML bodies.
Katano H; Ogawa-Goto K; Hasegawa H; Kurata T; Sata T
Virology; 2001 Aug; 286(2):446-55. PubMed ID: 11485412
[TBL] [Abstract][Full Text] [Related]
13. PML regulates p53 stability by sequestering Mdm2 to the nucleolus.
Bernardi R; Scaglioni PP; Bergmann S; Horn HF; Vousden KH; Pandolfi PP
Nat Cell Biol; 2004 Jul; 6(7):665-72. PubMed ID: 15195100
[TBL] [Abstract][Full Text] [Related]
14. Identification and characterization of HIPK2 interacting with p73 and modulating functions of the p53 family in vivo.
Kim EJ; Park JS; Um SJ
J Biol Chem; 2002 Aug; 277(35):32020-8. PubMed ID: 11925430
[TBL] [Abstract][Full Text] [Related]
15. HIPK2 contributes to PCAF-mediated p53 acetylation and selective transactivation of p21Waf1 after nonapoptotic DNA damage.
Di Stefano V; Soddu S; Sacchi A; D'Orazi G
Oncogene; 2005 Aug; 24(35):5431-42. PubMed ID: 15897882
[TBL] [Abstract][Full Text] [Related]
16. Role of nuclear bodies in apoptosis signalling.
Krieghoff-Henning E; Hofmann TG
Biochim Biophys Acta; 2008 Nov; 1783(11):2185-94. PubMed ID: 18680765
[TBL] [Abstract][Full Text] [Related]
17. Autoregulatory control of the p53 response by Siah-1L-mediated HIPK2 degradation.
Calzado MA; de la Vega L; Muñoz E; Schmitz ML
Biol Chem; 2009 Oct; 390(10):1079-83. PubMed ID: 19642869
[TBL] [Abstract][Full Text] [Related]
18. Effect of tyrosine autophosphorylation on catalytic activity and subcellular localisation of homeodomain-interacting protein kinases (HIPK).
van der Laden J; Soppa U; Becker W
Cell Commun Signal; 2015 Jan; 13():3. PubMed ID: 25630557
[TBL] [Abstract][Full Text] [Related]
19. Knocking down PML impairs p53 signaling transduction pathway and suppresses irradiation induced apoptosis in breast carcinoma cell MCF-7.
Bao-Lei T; Zhu-Zhong M; Yi S; Jun-Jie Q; Yan D; Hua L; Bin L; Guo-Wei Z; Zhi-Xian S
J Cell Biochem; 2006 Feb; 97(3):561-71. PubMed ID: 16215989
[TBL] [Abstract][Full Text] [Related]
20. Tyrosine kinase inhibitor, methyl 2,5-dihydromethylcinnimate, induces PML nuclear body formation and apoptosis in tumor cells.
Komura N; Asakawa M; Umezawa K; Segawa K
Exp Cell Res; 2007 Aug; 313(13):2753-65. PubMed ID: 17585903
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]